Q fever laboratory tests: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 7: Line 7:
===Serologic testing for Q fever:===
===Serologic testing for Q fever:===
   
   
*Indirect immunofluorescence (IIF) is the method of choice for antibody detection and is preferred over ELISA and complement fixation.
*Indirect immunofluorescence (IIF) is the method of choice for antibody detection and is preferred over ELISA and complement fixation.<ref name="urlDiagnosis of Q Fever">{{cite web |url=http://jcm.asm.org/content/36/7/1823.short |title=Diagnosis of Q Fever |format= |work= |accessdate=}}</ref><ref name="pmid7496944">{{cite journal |vauthors=Dupont HT, Thirion X, Raoult D |title=Q fever serology: cutoff determination for microimmunofluorescence |journal=Clin. Diagn. Lab. Immunol. |volume=1 |issue=2 |pages=189–96 |year=1994 |pmid=7496944 |pmc=368226 |doi= |url=}}</ref>
*Antibodies starts to be detected after 7-14 days of infection with most patients testing positive by the third week.
*Antibodies starts to be detected after 7-14 days of infection with most patients testing positive by the third week.
*Anti phase II antibodies are tested first. If positive, anti phase I antibodies are tested.
*Anti phase II antibodies are tested first. If positive, anti phase I antibodies are tested.
*After acute infection, serologic follow up for serum anti phase I IgG antibodies. The test is done twice every 3 months for 2 years. If it's positive, Transesophageal echo should be done to rule out endocarditis.
*After acute infection, serologic follow up for serum anti phase I IgG antibodies. The test is done twice every 3 months for 2 years. If it's positive, Transesophageal echo should be done to rule out endocarditis.<ref name="pmid6622891">{{cite journal |vauthors=Derrick EH |title="Q" fever, a new fever entity: clinical features, diagnosis and laboratory investigation |journal=Rev. Infect. Dis. |volume=5 |issue=4 |pages=790–800 |year=1983 |pmid=6622891 |doi= |url=}}</ref>
*All serologic test results should be used in the context of clinical data because false positive test results are seen in many other diseases (e.g. leptospirosis).     
*All serologic test results should be used in the context of clinical data because false positive test results are seen in many other diseases (e.g. leptospirosis).     
   
   
Line 16: Line 16:
   
   
*PCR can be used to detect C. brutenii DNA in cultures and clinical samples.
*PCR can be used to detect C. brutenii DNA in cultures and clinical samples.
*PCR is positive in the first week of infection, thus it can be used to diagnose Q fever in patients who are serologically negative in the early stages of the disease.
*PCR is positive in the first week of infection, thus it can be used to diagnose Q fever in patients who are serologically negative in the early stages of the disease.<ref name="pmid10515901">{{cite journal |vauthors=Maurin M, Raoult D |title=Q fever |journal=Clin. Microbiol. Rev. |volume=12 |issue=4 |pages=518–53 |year=1999 |pmid=10515901 |pmc=88923 |doi= |url=}}</ref>
*Quantitative PCR also can be used in patients whom anti phase II IgG antibodies are persistently positive to detect chronic Q fever.
*Quantitative PCR also can be used in patients whom anti phase II IgG antibodies are persistently positive to detect chronic Q fever.
   
   

Revision as of 21:09, 8 June 2017

Q fever Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Q fever from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications, and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary prevention

Secondary prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Q fever laboratory tests On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Q fever laboratory tests

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Q fever laboratory tests

CDC on Q fever laboratory tests

Q fever laboratory tests in the news

Blogs on Q fever laboratory tests

Directions to Hospitals Treating Q fever

Risk calculators and risk factors for Q fever laboratory tests

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Ahmed Younes M.B.B.CH [2]

Lab tests:

Serologic testing for Q fever:

  • Indirect immunofluorescence (IIF) is the method of choice for antibody detection and is preferred over ELISA and complement fixation.[1][2]
  • Antibodies starts to be detected after 7-14 days of infection with most patients testing positive by the third week.
  • Anti phase II antibodies are tested first. If positive, anti phase I antibodies are tested.
  • After acute infection, serologic follow up for serum anti phase I IgG antibodies. The test is done twice every 3 months for 2 years. If it's positive, Transesophageal echo should be done to rule out endocarditis.[3]
  • All serologic test results should be used in the context of clinical data because false positive test results are seen in many other diseases (e.g. leptospirosis).

Polymerase chain reaction (PCR):

  • PCR can be used to detect C. brutenii DNA in cultures and clinical samples.
  • PCR is positive in the first week of infection, thus it can be used to diagnose Q fever in patients who are serologically negative in the early stages of the disease.[4]
  • Quantitative PCR also can be used in patients whom anti phase II IgG antibodies are persistently positive to detect chronic Q fever.

Cultures:

  • C. brutenii doesn’t grow on ordinary blood cultures but can be cultivated on special media as embryonated eggs or cell culture.
  • C. brutenii is extremely infectious and samples should be handled with caution.

Liver function tests:

  • 2-3 fold increase in AST and ALT is seen in most of the patients.
  1. "Diagnosis of Q Fever".
  2. Dupont HT, Thirion X, Raoult D (1994). "Q fever serology: cutoff determination for microimmunofluorescence". Clin. Diagn. Lab. Immunol. 1 (2): 189–96. PMC 368226. PMID 7496944.
  3. Derrick EH (1983). ""Q" fever, a new fever entity: clinical features, diagnosis and laboratory investigation". Rev. Infect. Dis. 5 (4): 790–800. PMID 6622891.
  4. Maurin M, Raoult D (1999). "Q fever". Clin. Microbiol. Rev. 12 (4): 518–53. PMC 88923. PMID 10515901.